Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic Equivalence of Propofol 2% MCT Fresenius vs Diprivan in Elective Surgery
NCT01856998Phase 3Completed
- Sponsor
- Fresenius Kabi
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of propofol in general anesthesia (2 arms), sponsored by Fresenius Kabi. Primary endpoint: Time to Loss of Eyelash Reflex. Started May 2013; status: completed.
02
Drugs
propofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT01856998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856998.